These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 15662233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus.
    Rizzoni D, Porteri E, De Ciuceis C, Sleiman I, Rodella L, Rezzani R, Paiardi S, Bianchi R, Ruggeri G, Boari GE, Muiesan ML, Salvetti M, Zani F, Miclini M, Rosei EA.
    Hypertension; 2005 Apr; 45(4):659-65. PubMed ID: 15723969
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
    Malmqvist K, Kahan T, Dahl M.
    Am J Hypertens; 2000 May; 13(5 Pt 1):504-11. PubMed ID: 10826401
    [Abstract] [Full Text] [Related]

  • 4. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL, Pêgo M, Marquez E, Pujol M, Olivan J, Alegría E, Sagastagoitia-Gorostiza JD, Gonzalez-Juanatey JR.
    Clin Drug Investig; 2007 May; 27(6):407-17. PubMed ID: 17506591
    [Abstract] [Full Text] [Related]

  • 5. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D, Porteri E, Bettoni G, Piccoli A, Castellano M, Muiesan ML, Pasini G, Guelfi D, Rosei EA.
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African-American patients with hypertension.
    Papademetriou V, Narayan P, Kokkinos P.
    J Clin Hypertens (Greenwich); 2004 Jun; 6(6):310-4. PubMed ID: 15187493
    [Abstract] [Full Text] [Related]

  • 7. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
    Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T, Effect Study Group.
    Blood Press; 2001 Jun; 10(1):43-51. PubMed ID: 11332334
    [Abstract] [Full Text] [Related]

  • 8. Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.
    Sakamoto M, Suzuki H, Hayashi T, Iuchi H, Isaka T, Sakamoto N, Kayama Y, Tojo K, Yoshimura M, Utsunomiya K.
    Cardiovasc Diabetol; 2012 Oct 03; 11():118. PubMed ID: 23034088
    [Abstract] [Full Text] [Related]

  • 9. Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril.
    Ciulla MM, Paliotti R, Esposito A, Cuspidi C, Muiesan ML, Rosei EA, Magrini F, Zanchetti A.
    J Hypertens; 2009 Mar 03; 27(3):626-32. PubMed ID: 19262230
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
    Franke H.
    J Hum Hypertens; 1997 Sep 03; 11 Suppl 2():S61-2. PubMed ID: 9331010
    [No Abstract] [Full Text] [Related]

  • 11. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.
    Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, Lièvre M, Heemann U, Legendre C.
    Nephrol Dial Transplant; 2010 Mar 03; 25(3):967-76. PubMed ID: 19887503
    [Abstract] [Full Text] [Related]

  • 12. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group.
    Tanser PH, Campbell LM, Carranza J, Karrash J, Toutouzas P, Watts R.
    Am J Hypertens; 2000 Feb 03; 13(2):214-8. PubMed ID: 10701823
    [Abstract] [Full Text] [Related]

  • 13. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee JH, Yang DH, Hwang JY, Hur SH, Cha TJ, Kim KS, Kim MH, Chun KJ, Cha GS, Hong GR, Lee SG, Kim DS, Kim DI, Chae SC.
    Clin Ther; 2016 Jun 03; 38(6):1485-1497. PubMed ID: 27161546
    [Abstract] [Full Text] [Related]

  • 14. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
    Zanchetti A, Omboni S.
    Am J Hypertens; 2001 Feb 03; 14(2):129-34. PubMed ID: 11243303
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N.
    Clin Ther; 2012 Apr 03; 34(4):838-48. PubMed ID: 22440192
    [Abstract] [Full Text] [Related]

  • 16. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R, Zoppi A, Salvadeo SA, Mugellini A, Lazzari P, Santoro T, Derosa G.
    Hypertens Res; 2011 Apr 03; 34(4):509-15. PubMed ID: 21179101
    [Abstract] [Full Text] [Related]

  • 17. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
    Asmar R, Porcellati C, Dusing R.
    Drugs Exp Clin Res; 2004 Apr 03; 30(4):153-61. PubMed ID: 15553661
    [Abstract] [Full Text] [Related]

  • 18. Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study.
    Ketelhut R, Bramlage P.
    Clin Drug Investig; 2010 Apr 03; 30(5):301-11. PubMed ID: 20384386
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
    Tikkanen I, Omvik P, Jensen HA.
    J Hypertens; 1995 Nov 03; 13(11):1343-51. PubMed ID: 8984133
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan.
    Ogihara T, Arakawa K.
    J Hum Hypertens; 1999 Jan 03; 13 Suppl 1():S27-31; discussion S33-4. PubMed ID: 10076918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.